富豪西營盤「尚瓏」首推50伙 折實入場價688.1萬元
富豪酒店集團(00078.HK)旗下西營盤皇后大道西160號住宅項目「尚瓏」公布首張價單,涉及50伙,其中開放式佔8伙、一房佔25伙及兩房佔17伙,實用面積由242至431平方呎。售價介乎819.17萬至1,614.1萬元。計及最高16%折扣,折實價介乎688.1萬元至1,355.8萬元;折實呎價介乎27,972元至31,626元。
富豪酒店集團執行董事范統在記者會上表示,項目首張價單折實平均呎價30,299元,認為是接近市價推出,相信同區同類供應少,項目亦僅130伙,市場容易消化。
他稱項目明日(4月1日)會開放示範單位,隨後開始收票,預期復活節假後最快約4月中旬開賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.